Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Drug Name||RV-NY-ESO TCR PBMC|
|Synonyms||RV-NYESO TCR PBMC|
RV-NY-ESO TCR PBMC are peripheral blood mononuclear cells that have been engineered to express an NY-ESO-1-specific T-cell receptor, which may result in enhanced anti-tumor immunity (PMID: 25038231, PMID: 30409823).
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Aldesleukin + Cyclophosphamide + Fludarabine + RV-NY-ESO TCR PBMC||Aldesleukin Cyclophosphamide Fludarabine RV-NY-ESO TCR PBMC||0||0|
|Aldesleukin + LV-NY-ESO TCR/sr39TK PBSC + RV-NY-ESO TCR PBMC||Aldesleukin LV-NY-ESO TCR/sr39TK PBSC RV-NY-ESO TCR PBMC||0||2|
|RV-NY-ESO TCR PBMC||RV-NY-ESO TCR PBMC||0||0|